Cysteinyl proteinases and their selective inactivation
- PMID: 2407065
- DOI: 10.1002/9780470123096.ch5
Cysteinyl proteinases and their selective inactivation
Abstract
The affinity-labeling of cysteinyl proteinases may now be carried out with a number of peptide-derived reagents with selectivity, particularly for reactions carried out in vitro. These reagents have been described with emphasis on their selectivity for cysteine proteinases and lack of action on serine proteinases, the most likely source of side reactions among proteinases. Perhaps a crucial feature of this selectivity is an enzyme-promoted activation due to initial formation of a hemiketal, which may destabilize the reagent. Prominent among the reagent types that have this class selectivity are the peptidyl diazomethyl ketones, the acyloxymethyl ketones, the peptidylmethyl sulfonium salts, and peptidyl oxides analogous to E-64. The need for specific inhibitors capable of inactivating the target enzyme in intact cells and animals is inevitably pushing the biochemical application of these inhibitors into more complex molecular environments where the possibilities of competing reactions are greatly increased. In dealing with the current state and potential developments for the in vivo use of affinity-labeling reagents of cysteine proteinases, the presently known variety of cysteinyl proteinases had to be considered. Therefore this chapter has, at the same time, attempted to survey these proteinases with respect to specificity and gene family. The continual discovery of new proteinases will increase the complexity of this picture. At present the lysosomal cysteine proteinases cathepsins B and L and the cytoplasmic calcium-dependent proteinases are reasonable goals for a fairly complete metabolic clarification. The ability of investigators to inactivate individual members of this family in vivo, possibly without complications due to concurrent inactivation of serine proteinases by improvements in reagent specificity, is increasing. Among the cysteine proteinases, at least those of the papain super family, hydrophobic interactions in the S2 and S3 subsites are important and some specificity has been achieved by taking advantage of topographical differences among members of this group. Some of this has probably involved surface differences removed from the regions involved in proteolytic action. The emerging cysteine proteinases include some which, in contrast to the papain family, have a pronounced specificity in S1 for the binding of basic side chains, familiar in the trypsin family of serine proteinases. At least a potential conflict with serine proteinases can be avoided by choice of a covalent bonding mechanism. The departing group region, has not been exploited. As a sole contributor to binding, this region may be rather limited as a source of specificity.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Novel N-peptidyl-O-acyl hydroxamates: selective inhibitors of cysteine proteinases.Biochim Biophys Acta. 1993 Oct 6;1202(2):271-6. doi: 10.1016/0167-4838(93)90015-j. Biochim Biophys Acta. 1993. PMID: 8399390
-
Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.Biochem J. 1996 Sep 1;318 ( Pt 2)(Pt 2):395-9. doi: 10.1042/bj3180395. Biochem J. 1996. PMID: 8809025 Free PMC article.
-
The properties of peptidyl diazoethanes and chloroethanes as protease inactivators.Arch Biochem Biophys. 1989 Apr;270(1):286-93. doi: 10.1016/0003-9861(89)90030-1. Arch Biochem Biophys. 1989. PMID: 2930191
-
Novel cysteine proteinase inhibitors homologous to the proregions of cysteine proteinases.Curr Protein Pept Sci. 2002 Apr;3(2):231-8. doi: 10.2174/1389203024605331. Curr Protein Pept Sci. 2002. PMID: 12188906 Review.
-
Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.Biol Chem. 1997 Mar-Apr;378(3-4):141-50. Biol Chem. 1997. PMID: 9165064 Review.
Cited by
-
Mechanistic insights into mode of action of novel natural cathepsin L inhibitors.BMC Genomics. 2013;14 Suppl 8(Suppl 8):S10. doi: 10.1186/1471-2164-14-S8-S10. Epub 2013 Dec 9. BMC Genomics. 2013. PMID: 24564425 Free PMC article.
-
Rational design of a selective covalent modifier of G protein βγ subunits.Mol Pharmacol. 2011 Jan;79(1):24-33. doi: 10.1124/mol.110.068155. Epub 2010 Sep 29. Mol Pharmacol. 2011. PMID: 20881007 Free PMC article.
-
Affinity labelling of the Ca(2+)-activated neutral proteinase (calpain) in intact human platelets.Biochem J. 1993 Jan 1;289 ( Pt 1)(Pt 1):93-9. doi: 10.1042/bj2890093. Biochem J. 1993. PMID: 8424777 Free PMC article.
-
Identification and optimization of a novel inhibitor of mitochondrial calpain 10.J Med Chem. 2009 Jan 8;52(1):181-8. doi: 10.1021/jm800735d. J Med Chem. 2009. PMID: 19072163 Free PMC article.
-
Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation.J Exp Med. 2002 Aug 19;196(4):493-503. doi: 10.1084/jem.20011836. J Exp Med. 2002. PMID: 12186841 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials